With 0.54 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.57 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $0.482 whereas the lowest price it dropped to was $0.451. The 52-week range on ADVB shows that it touched its highest point at $4.10 and its lowest point at $0.34 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ADVB was up-trending over the past week, with a rise of 2.24%, but this was down by -1.22% over a month. Three-month performance surged to 19.28% while six-month performance fell -77.76%.
Float and Shares Shorts:
At present, 21.64 million ADVB shares are outstanding with a float of 3.08 million shares on hand for trading. On 2025-10-15, short shares totaled 0.12 million, which was 54.99999999999999 higher than short shares on 1757894400. In addition to Dr. Yi Lu Ph.D. as the firm’s CEO & Chairman, Mr. Mingze Yin serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.00607 of ADVB’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, ADVB reported revenue of $0.0 and operating income of -$762739.0. The EBITDA in the recently reported quarter was -$62624.0 and diluted EPS was -$0.07.
